Review: 'Through the Shadowlands’ describes Julie Rehmeyer's ME/CFS Odyssey
I should note at the outset that this review is based on an audio version of the galleys and the epilogue from the finished work. Julie Rehmeyer sent me the final version as a PDF, but for some reason my text to voice software (Kurzweil) had issues with it. I understand that it is...
Discuss the article on the Forums.

Merck’s Zostavax draws new litigation from patients alleging contract Shingles 7/21/17 FiercePharma

Discussion in 'Other Health News and Research' started by *GG*, Jul 27, 2017.

  1. *GG*

    *GG* senior member

    Concord, NH
    Even as Merck & Co. confronts the prospect of a tough market competitor in GlaxoSmithKline’s Shingrix, the drugmaker’s shingles vaccine Zostavax faces a growing challenge in court.

    Eighteen patients have filed a liability lawsuit against Merck, alleging the company produced and sold an “unreasonably dangerous vaccine” that caused serious injuries after vaccination. Hailing from a range of states including Louisiana, South Carolina, Tennessee, Michigan and Wisconsin, the plaintiffs filed their suit in Merck’s home state of New Jersey.

    Little Bluestem and ScottTriGuy like this.

See more popular forum discussions.

Share This Page